001     276158
005     20250209000723.0
024 7 _ |a 10.1038/s41551-024-01278-4
|2 doi
024 7 _ |a pmid:39633028
|2 pmid
024 7 _ |a altmetric:171518508
|2 altmetric
037 _ _ |a DZNE-2025-00230
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Yin, Jiang-An
|0 P:(DE-2719)9002756
|b 0
245 _ _ |a Arrayed CRISPR libraries for the genome-wide activation, deletion and silencing of human protein-coding genes.
260 _ _ |a Tokyo
|c 2025
|b Nature Research
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1738669476_26729
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Arrayed CRISPR libraries extend the scope of gene-perturbation screens to non-selectable cell phenotypes. However, library generation requires assembling thousands of vectors expressing single-guide RNAs (sgRNAs). Here, by leveraging massively parallel plasmid-cloning methodology, we show that arrayed libraries can be constructed for the genome-wide ablation (19,936 plasmids) of human protein-coding genes and for their activation and epigenetic silencing (22,442 plasmids), with each plasmid encoding an array of four non-overlapping sgRNAs designed to tolerate most human DNA polymorphisms. The quadruple-sgRNA libraries yielded high perturbation efficacies in deletion (75-99%) and silencing (76-92%) experiments and substantial fold changes in activation experiments. Moreover, an arrayed activation screen of 1,634 human transcription factors uncovered 11 novel regulators of the cellular prion protein PrPC, screening with a pooled version of the ablation library led to the identification of 5 novel modifiers of autophagy that otherwise went undetected, and 'post-pooling' individually produced lentiviruses eliminated template-switching artefacts and enhanced the performance of pooled screens for epigenetic silencing. Quadruple-sgRNA arrayed libraries are a powerful and versatile resource for targeted genome-wide perturbations.
536 _ _ |a 354 - Disease Prevention and Healthy Aging (POF4-354)
|0 G:(DE-HGF)POF4-354
|c POF4-354
|f POF IV
|x 0
536 _ _ |a 899 - ohne Topic (POF4-899)
|0 G:(DE-HGF)POF4-899
|c POF4-899
|f POF IV
|x 1
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a RNA, Guide, CRISPR-Cas Systems
|2 NLM Chemicals
650 _ 7 |a Transcription Factors
|2 NLM Chemicals
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Gene Silencing
|2 MeSH
650 _ 2 |a CRISPR-Cas Systems: genetics
|2 MeSH
650 _ 2 |a Genome, Human: genetics
|2 MeSH
650 _ 2 |a Gene Library
|2 MeSH
650 _ 2 |a RNA, Guide, CRISPR-Cas Systems: genetics
|2 MeSH
650 _ 2 |a Plasmids: genetics
|2 MeSH
650 _ 2 |a Gene Deletion
|2 MeSH
650 _ 2 |a HEK293 Cells
|2 MeSH
650 _ 2 |a Clustered Regularly Interspaced Short Palindromic Repeats: genetics
|2 MeSH
650 _ 2 |a Transcription Factors: genetics
|2 MeSH
650 _ 2 |a Transcription Factors: metabolism
|2 MeSH
700 1 _ |a Frick, Lukas
|b 1
700 1 _ |a Scheidmann, Manuel C
|b 2
700 1 _ |a Liu, Tingting
|b 3
700 1 _ |a Trevisan, Chiara
|0 0000-0002-3997-094X
|b 4
700 1 _ |a Dhingra, Ashutosh
|0 P:(DE-2719)2811729
|b 5
|u dzne
700 1 _ |a Spinelli, Anna
|b 6
700 1 _ |a Wu, Yancheng
|0 0000-0003-2809-4865
|b 7
700 1 _ |a Yao, Longping
|b 8
700 1 _ |a Vena, Dalila Laura
|0 0009-0007-6863-7349
|b 9
700 1 _ |a Knapp, Britta
|b 10
700 1 _ |a Guo, Jingjing
|b 11
700 1 _ |a De Cecco, Elena
|b 12
700 1 _ |a Ging, Kathi
|b 13
700 1 _ |a Armani, Andrea
|0 0000-0002-4765-9748
|b 14
700 1 _ |a Oakeley, Edward J
|0 0000-0001-6226-7470
|b 15
700 1 _ |a Nigsch, Florian
|0 0000-0002-2919-8749
|b 16
700 1 _ |a Jenzer, Joel
|b 17
700 1 _ |a Haegele, Jasmin
|b 18
700 1 _ |a Pikusa, Michal
|b 19
700 1 _ |a Täger, Joachim
|0 P:(DE-2719)2811804
|b 20
|u dzne
700 1 _ |a Rodriguez-Nieto, Salvador
|0 P:(DE-2719)2812129
|b 21
|u dzne
700 1 _ |a Bouris, Vangelis
|b 22
700 1 _ |a Ribeiro, Rafaela
|b 23
700 1 _ |a Baroni, Federico
|b 24
700 1 _ |a Bedi, Manmeet Sakshi
|b 25
700 1 _ |a Berry, Scott
|b 26
700 1 _ |a Losa, Marco
|0 0000-0003-3428-418X
|b 27
700 1 _ |a Hornemann, Simone
|0 0000-0002-2674-9891
|b 28
700 1 _ |a Kampmann, Martin
|b 29
700 1 _ |a Pelkmans, Lucas
|b 30
700 1 _ |a Hoepfner, Dominic
|b 31
700 1 _ |a Heutink, Peter
|0 P:(DE-2719)2810728
|b 32
700 1 _ |a Aguzzi, Adriano
|b 33
773 _ _ |a 10.1038/s41551-024-01278-4
|g Vol. 9, no. 1, p. 127 - 148
|0 PERI:(DE-600)2878897-7
|n 1
|p 127 - 148
|t Nature biomedical engineering
|v 9
|y 2025
|x 2157-846X
856 4 _ |u https://pub.dzne.de/record/276158/files/DZNE-2025-00230%20SRC.xlsx
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/276158/files/DZNE-2025-00230.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/276158/files/DZNE-2025-00230.pdf?subformat=pdfa
856 4 _ |u https://pub.dzne.de/record/276158/files/DZNE-2025-00230%20SRC.csv
856 4 _ |u https://pub.dzne.de/record/276158/files/DZNE-2025-00230%20SRC.ods
856 4 _ |u https://pub.dzne.de/record/276158/files/DZNE-2025-00230%20SRC.xls
909 C O |o oai:pub.dzne.de:276158
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)2811729
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 20
|6 P:(DE-2719)2811804
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 21
|6 P:(DE-2719)2812129
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 32
|6 P:(DE-2719)2810728
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-354
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Prevention and Healthy Aging
|x 0
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 1
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-30
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT BIOMED ENG : 2022
|d 2024-12-30
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-30
915 _ _ |a DEAL Nature
|0 StatID:(DE-HGF)3003
|2 StatID
|d 2024-12-30
|w ger
915 _ _ |a IF >= 25
|0 StatID:(DE-HGF)9925
|2 StatID
|b NAT BIOMED ENG : 2022
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-30
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-30
920 1 _ |0 I:(DE-2719)1210002
|k AG Heutink
|l Genome Biology of Neurodegenerative Diseases
|x 0
920 1 _ |0 I:(DE-2719)5000002
|k AG Täger
|l Cellomics Facility
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1210002
980 _ _ |a I:(DE-2719)5000002
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21